Literature DB >> 1330175

Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype.

G Molderings1, B Malinowska, E Schlicker.   

Abstract

1. In segments of the rat vena cava preincubated with [3H]-noradrenaline and superfused with physiological salt solution (containing desipramine and corticosterone), we studied the effects of prostaglandins of the D, E and F series, of a prostacyclin analogue and a thromboxane-mimetic and of subtype-selective prostaglandin E-receptor (EP-receptor) ligands on the electrically (0.66 Hz)-evoked tritium overflow. 2. The electrically-evoked tritium overflow was inhibited by prostaglandin E2 (maximum inhibition by about 80%; pIC40 7.49). The effect of prostaglandin E2 was not affected by rauwolscine, which, by itself, increased the evoked overflow; the alpha 2-adrenoceptor antagonist was added to the superfusion medium in all subsequent experiments. Indomethacin failed to affect either the evoked tritium overflow or its inhibition by prostaglandin E2. 3. The inhibitory effect of prostaglandin E2 on the electrically-evoked tritium overflow was not altered by the EP1-receptor antagonist. AH 6809 (6-isopropoxy-9-oxoxanthene-2-carboxylic acid) at a concentration at least 30 fold higher than its pA2 value at EP1-receptors. The following compounds mimicked the effect of prostaglandin E2 showing the following rank order of potencies: misoprostol (EP2-/EP3-receptor agonist) congruent to sulprostone (EP1-/EP3-receptor agonist) congruent to prostaglandin E1 = prostaglandin E2 >> iloprost (EP1-/IP-receptor agonist) = prostaglandin F2 alpha. The evoked overflow was not affected by high concentrations of prostaglandin D2 or the thromboxane-mimetic U46619 (9,11-dideoxy-11 alpha, 9 alpha-epoxy-methano-prostaglandin F2 alpha). 4. The present results suggest that the postganglionic sympathetic nerve fibres innervating the rat vena cava are endowed with presynaptic EP3-receptors.They are not tonically activated by endogenously formed products of cyclo-oxygenase and do not interact with the presynaptic M2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330175      PMCID: PMC1907842          DOI: 10.1111/j.1476-5381.1992.tb12750.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Mutual interaction between presynaptic alpha 2-adrenoceptors and 5-HT1B receptors on the sympathetic nerve terminals of the rat inferior vena cava.

Authors:  G J Molderings; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

2.  Noradrenaline release in the rat vena cava is inhibited by gamma-aminobutyric acid via GABAB receptors but not affected by histamine.

Authors:  D Schneider; E Schlicker; B Malinowska; G Molderings
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  Prostaglandin action on noradrenaline release and mechanical responses in the stimulated guinea pig vas deferens.

Authors:  P Hedqvist
Journal:  Acta Physiol Scand       Date:  1974-01

4.  Endogenous noradrenaline impairs the prostaglandin-induced inhibition of noradrenaline release.

Authors:  C Allgaier; T Jäger; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

5.  Prejunctional inhibitory effects of prostanoids on sympathetic neurotransmission in the rabbit iris-ciliary body.

Authors:  S E Ohia; J E Jumblatt
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

6.  Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava.

Authors:  G J Molderings; K Fink; E Schlicker; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

7.  Prejunctional prostaglandin receptors in the human iris-ciliary body.

Authors:  S E Ohia; J E Jumblatt
Journal:  Curr Eye Res       Date:  1991-10       Impact factor: 2.424

8.  Neuroeffector actions of prostaglandin D2 on isolated dog mesenteric arteries.

Authors:  M Nakajima; N Toda
Journal:  Prostaglandins       Date:  1984-03

9.  Prejunctional prostanoid receptors on cardiac adrenergic terminals belong to the EP3 subtype.

Authors:  L Mantelli; S Amerini; A Rubino; F Ledda
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

Review 10.  Prostaglandins and the release of the adrenergic transmitter.

Authors:  K U Malik; E Sehic
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

View more
  9 in total

1.  Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.

Authors:  L Walch; V de Montpreville; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Modulation of noradrenaline release in rat isolated stomach by prostanoids, but not by histaminergic mechanisms.

Authors:  K Racké; L Berrino; A Möhlig; R Jäger; I Griepenkerl; M Bräutigam; A Reimann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

3.  Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation.

Authors:  G J Molderings; S Menzel; M Kathmann; E Schlicker; M Göthert
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

4.  Protective effects of amphetamine on gastric ulcerations induced by indomethacin in rats.

Authors:  Vlaicu Sandor; Barbu Cuparencu; Dan-L Dumitrascu; Mircea-A Birt; Tibor-L Krausz
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

5.  Interaction of prostanoid EP₃ and TP receptors in guinea-pig isolated aorta: contractile self-synergism of 11-deoxy-16,16-dimethyl PGE₂.

Authors:  R L Jones; D F Woodward
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

6.  Prostanoid receptors of the EP3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex.

Authors:  H J Exner; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

7.  Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.

Authors:  G J Molderings; E Colling; J Likungu; J Jakschik; M Göthert
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

8.  E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype.

Authors:  Deborah L Clarke; Mark A Giembycz; Hema J Patel; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

9.  Expression and site-directed mutagenesis of mouse prostaglandin E2 receptor EP3 subtype in insect cells.

Authors:  C Huang; H H Tai
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.